Sector: Healthcare

Small Cap

Invicta Diagnostic Share Price

INVICTA

₹68.50

1.45(2.16%)

19th Aug 2026 | 9:38 AM

NSE : INVICTA

Open Free Demat Account

Invicta Diagnostic Performance

Price Movement

₹68.50

₹68.45

₹68.50

↘ Today's Low↗ Today's High

1 Year Performance

₹68.50

₹58.10

₹105.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹68.50

Low₹68.45

Open at₹68.45

Prev Close₹67.05

Volumes6.40 K

Avg Price₹68.48

Lower Circuit₹53.65

Upper Circuit₹80.45

Historical Performance

3M High₹89.50

3M Low₹58.70

1 Yr High₹105.00

1 Yr Low₹58.10

3 Yr High₹105.00

3 Yr Low₹58.10

5 Yr High₹105.00

5 Yr Low₹58.10

Summary

As of 19-08-2026 15:11, Invicta Diagnostic Ltd. share price today is ₹0, with a change of ₹-67.05 (-100.00%) from the previous close of ₹67.05. The stock opened at ₹68.45 and traded between ₹68.45 and ₹68.5, with a total traded volume of 6400 shares. The company has a market capitalization of ₹91.8 Cr in the Healthcare sector. while its 52-week high and low are ₹105 and ₹58.1, respectively.

Invicta Diagnostic Ltd. valuation metrics include a P/E ratio of 18.7, EPS of ₹4.9, and book value of ₹1.80. Profitability indicators show ROE of 9.82%.

Invicta Diagnostic Ltd. technical indicators include Day RSI at 53.31, Day MFI at 85.26, Day ADX at 21.26. Additional indicators include Commodity Channel Index (CCI) at 28.5 and Williams %R at -50. Momentum indicators show Day MACD at 1.82, Day MACD Signal Line at 1.68, DayATR at 2.52. Rate of Change indicators for Invicta Diagnostic Ltd. include ROC125 at 13.27 and ROC21 at 8.15.

Exponential moving averages include EMA5 at ₹74.1, EMA10 at ₹73.8, EMA12 at ₹73.5, EMA20 at ₹72.3, EMA26 at ₹71.7, EMA50 at ₹71.1, EMA100 at ₹71.2. Simple moving averages include SMA5 at ₹74.8, SMA10 at ₹75.5, SMA20 at ₹71.2, SMA30 at ₹70.4, SMA50 at ₹68, SMA100 at ₹72.7, SMA150 at ₹71.7.

Support levels for Invicta Diagnostic are placed at First Support ₹73.00, Second Support ₹73.00, Third Support ₹73.00. Resistance levels are seen at First Resistance ₹73.00, Second Resistance ₹73.00, Third Resistance ₹73.00. Invicta Diagnostic Ltd. shareholding pattern shows promoter holding at 66.7%, FII holding at 4.2%, DII holding at 0%, public holding at 24.81%.

Invicta Diagnostic Fundamentals

Market Cap

Below industry Median

91.80 Cr.

PE Ratio (TTM)

Below industry Median

18.70

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

64% decr over last year

9.82

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

Below industry Median

1.80

MFI

MFI strongly Overbought

85.26

RSI

RSI is mid-range

53.31

EPS (TTM)

4.90

Debt to Equity

0.07

Face Value

Operating Profit Margin Qtr.

29.55

Operating Profit Qtr.

3.87

Net Profit Qtr.

2.01

Operating Revenue Qtr.

8.37

PB Ratio

1.80

Invicta Diagnostic Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2024
Total Revenue	3.82
Operating Expense	1.95
Operating Profit	1.86
Depreciation	0.38
Interest	0.01
Tax	0.37
Net Profit	2.20

Invicta Diagnostic Technicals

Invicta Diagnostic Ltd. EMA & SMA

₹68.50

-4.50 (-6.16%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹74.1

Day EMA10 ₹73.8

Day EMA12 ₹73.5

Day EMA20 ₹72.3

Day EMA26 ₹71.7

Day EMA50 ₹71.1

Day EMA100 ₹71.2

Invicta Diagnostic Support and Resistance

Resistance

First Resistance₹73.00

Second Resistance₹73.00

Third Resistance₹73.00

Support

First Support₹73.00

Second Support₹73.00

Third Support₹73.00

Technical Indicators

Day RSI53.31

Day MFI85.26

Day ADX21.26

Day Commodity Channel Index28.50

William-50.00

Day MACD1.82

Day MACD Signal Line1.68

Day ATR2.52

Day ROC12513.27

Day ROC218.15

Invicta Diagnostic Shareholding Pattern

Held By	Mar 2026
Promoter	66.7
FII	4.2
DII	4.3
Public	24.8

Invicta Diagnostic Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	3.2 K	3.2 K	100.00%
Week	8 K	10.8 K	74.07%
1 Month	17.42 K	19.11 K	91.16%
6 Month	22.74 K	25.34 K	89.77%

Invicta Diagnostic SWOT Analysis

Strengths6

Weakness3

Opportunity0

Threats0

Annual Profit Growth higher than Sector Profit Growth

Overbought by Money Flow Index (MFI)

Companies with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Invicta Diagnostic Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Invicta Diagnostic Stock Comparison

Financials	Avience Biomedicals Ltd.	Q-Line Biotech Ltd.	Gujarat Kidney and Super Speciality Ltd.	VijayPD Ceutical Ltd.	Galaxy Medicare Ltd.
Price (₹)	₹236.05	₹514.50	₹158.39	₹60	₹18.50
% Change	-0.82%	-1.82%	3.21%	0.00%	-0.54%
Revenue TTM (₹ Cr)	-	-	₹101.04	-	-
Net Profit TTM (₹ Cr)	-	-	₹15.83	-	-
PE TTM	10.90	22.20	75.40	23.40	8.70
1 Year Return	13.94	54.27	32.77	71	-63.89
ROCE	31.13	26.65	8.56	14.18	-

Similar Stocks

No Data Available

FAQ's on INVICTA

What is the Market Capitalization of Invicta Diagnostic Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 17 August 2026, the market cap for Invicta Diagnostic Ltd. is approximately ₹ 91.8 Cr.

What are the PE and PB ratios for Invicta Diagnostic Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Invicta Diagnostic Ltd. is 18.7, and the Price-to-Book (PB) ratio is 1.8.

What is the 52-Week High and Low for Invicta Diagnostic Ltd.?

Over the past 52 weeks, the highest price reached by Invicta Diagnostic Ltd. shares was ₹ 105, and the lowest price was ₹ 58.1.

Who are the major shareholders of Invicta Diagnostic Ltd.?

Significant shareholdings in Invicta Diagnostic Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Invicta Diagnostic Ltd. in the Healthcare sector?

In the Healthcare sector, Invicta Diagnostic Ltd. is often compared with other major players such as Molbio Diagnostics, Manipal Health Enterprises, Avience Biomedicals, QLine Biotech, Hannah Joseph Hospital and Modern Diagnostic Research for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy